RxLibra

Search Generic Medicine

Medicine Index

Search by generic name

Tag: Prostate Cancer

Generic Rucaparib

Rucaparib is an orally bioavailable tricyclic indole and inhibitor of poly(ADP-ribose) polymerases (PARPs) 1 (PARP1), 2 (PARP2) and 3 (PARP3), with potential chemo/radiosensitizing and antineoplastic activities. Upon administration, rucaparib selectively binds to PARP1, 2 and 3 and inhibits PARP-mediated DNA repair. This enhances the accumulation of DNA strand breaks, promotes . . . Read more

Generic Apalutamide

Apalutamide is a nonsteroidal antiandrogen medication,Apalutamide is approved to treat Prostate cancer. It is used: In patients whose cancer has metastasized (spread to other parts of the body) and is castration sensitive (has responded to treatments that lower testosterone levels). In patients whose cancer has not metastasized and is castration . . . Read more

Generic Enzalutamide

Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic activity. Enzalutamide is approved to treat: In patients whose cancer is castration resistant (has not responded to treatments that lower testosterone levels). In patients whose cancer has metastasized and is castration sensitive (has . . . Read more

Generic Abiraterone

Abiraterone is in a class of medications called androgen biosynthesis inhibitors (17 alpha-hydroxylase/C17,20-lyase,CYP17 inhibitor) . It works by decreasing the amount of certain hormones in the body.Abiraterone acetate is approved to be used with prednisone to treat Prostate cancer that has metastasized (spread to other parts of the body). It . . . Read more

Generic Olaparib

Olaparib is a small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib is approved to treat: Breast cancer that is HER2 negative, has certain germline mutations in the BRCA1 or BRCA2 gene, and has metastasized (spread to other parts of the . . . Read more